GlassScriptPhysician profile
Jane Jinyan Chen
NPI 1588123699
$1,568.73
in general payments reported to CMS, 2019-2025
21 companies · $379 in 2025
The $379 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $350 · 2022: $17.43 · 2023: $363 · 2024: $459 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,201.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $325.00 | 2020 | |
| Mayne Pharma Commercial LLC | $265.14 | 2023-2025 | |
| Astellas Pharma US INC | $194.40 | 2023-2025 | Veozah |
| Abbott Laboratories | $159.37 | 2023 | Proclaim |
| Shield Therapeutics INC | $91.33 | 2024-2025 | |
| Organon LLC | $81.19 | 2022-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $80.90 | 2023-2025 | Myfembree |
| Lilly USA, LLC | $58.65 | 2024-2025 | Zepbound |
| Biogen, INC. | $47.96 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $40.07 | 2023 | Lo Loestrin Fe |
| Exeltis, USA INC. | $33.03 | 2023-2024 | Slynd |
| Evofem Biosciences, INC. | $28.33 | 2024-2025 | Phexxi, Solosec, Phexx |
| Pacira Pharmaceuticals Incorporated | $25.92 | 2025 | Exparel |
| Davol INC. | $25.09 | 2020 | |
| Cepheid | $21.71 | 2024 | Genexpert |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15.81 | 2024 | Evenity, Prolia |
| Exact Sciences Corporation | $15.53 | 2023 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $15.36 | 2025 | |
| Pfizer INC. | $15.13 | 2025 | |
| Novo Nordisk INC | $14.62 | 2024 | Wegovy |
| Sanofi Pasteur INC. | $14.19 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.